DBV Technologies SA
0.6940
27-November-24 04:33:25
15 minutes delayed
Stocks
+0.0980
+16.44%
Today's range
0.6360 - 0.7200
ISIN
FR0010417345
Source
Cboe
-
DBV Technologies to Report First Quarter 2022 Financial Results and Recent Business Developments
25 Apr 2022 16:30:00 By Nasdaq GlobeNewswire
-
Ordinary and Extraordinary General Meeting of May 12, 2022
21 Apr 2022 16:30:00 By Nasdaq GlobeNewswire
-
14 Apr 2022 16:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies to Present at the Oppenheimer’s 32nd Annual Healthcare Conference
14 Mar 2022 16:30:00 By Nasdaq GlobeNewswire
-
11 Mar 2022 16:30:00 By Nasdaq GlobeNewswire
-
09 Mar 2022 16:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates
03 Mar 2022 16:15:00 By Nasdaq GlobeNewswire
-
DBV Technologies to Report Full Year 2021 Financial Results and Business Updates on March 3, 2022
24 Feb 2022 16:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies to Participate in Upcoming AAAAI 2022 Congress
22 Feb 2022 16:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies to Present at the 11th Annual SVB Leerink Global Healthcare Conference
14 Feb 2022 16:30:00 By Nasdaq GlobeNewswire
-
09 Feb 2022 16:30:00 By Nasdaq GlobeNewswire
-
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
21 Jan 2022 16:30:00 By Nasdaq GlobeNewswire
-
12 Jan 2022 16:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies to Present at the H.C. Wainwright BioConnect 2022 Conference
07 Jan 2022 01:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies Provides Update on Investigational Viaskin™ Peanut
20 Dec 2021 16:15:00 By Nasdaq GlobeNewswire
-
10 Dec 2021 16:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies to Participate in an Upcoming Investor Conference
24 Nov 2021 01:30:00 By Nasdaq GlobeNewswire
-
04 Nov 2021 16:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies to Highlight New Long-term Data from REALISE Trial at ACAAI 2021
01 Nov 2021 02:30:00 By Nasdaq GlobeNewswire
-
DBV Technologies Reports Third Quarter 2021 Financial Results and Recent Regulatory Developments
26 Oct 2021 16:15:00 By Nasdaq GlobeNewswire